ALTH » Topics » Financial Highlights and 2009 Guidance

This excerpt taken from the ALTH 8-K filed Mar 3, 2009.

Financial Highlights and 2009 Guidance


The Company ended 2008 with cash, cash equivalents and investments in marketable securities totaling $84.0 million.  Net cash used in operating activities during 2008 was approximately $42.9 million, below the Company’s prior guidance of $45 to $49 million dollars.


For fiscal year 2009, the Company anticipates that net cash use in operating activities will approximate $50 to $54 million dollars.  Though not inclusive of all costs associated with the potential future launch of pralatrexate, this guidance includes the phase-in of certain key investments related to commercial planning and pre-commercial scale-up of manufacturing for pralatrexate, as well as $6.8 million of potential milestone payments under the Company’s license agreement for pralatrexate payable upon FDA acceptance and approval of the Company’s NDA.


The Company retains exclusive worldwide commercial rights to pralatrexate for all indications.  If approved for marketing, the Company intends to commercialize pralatrexate by building an oncology-focused U.S. sales and marketing organization.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki